Medication info

Ranitid Tablet (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
TDS Pharm Co., Ltd.
Appearance
Cream to pale yellow round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 200403007 · Notified 2004.05.12

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson's syndrome
Who takes it
Adults · Children
Adult dose
Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The same dosage and administration apply to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Reflux esophagitis: Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. Zollinger-Ellison syndrome: Begin treatment with an initial dose of 150 mg of this medicine 3 times daily, and increase the dose as needed. For severe cases, up to 6 g per day may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg of this medicine twice daily. Preanesthetic medication (prevention of Mendelson syndrome): Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is also preferable to administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis: Administer 150 mg of this medicine once daily at bedtime. For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Child dose
Ages 8 〜 18 years: 150 mg per dose (2 mg per kg of body weight) may be administered up to twice daily. Patients 12 years of age and older: Administer 75 mg of this medicine orally twice daily (liquid formulation only).

Ingredients

Manufacturer
TDS Pharm Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by NSAID administration
  • gastric mucosal erosion
  • gastric mucosal bleeding
  • gastric mucosal redness
  • gastric mucosal swelling
  • acute gastritis
  • acute exacerbation of chronic gastritis
View approved original text

This medication is used for the treatment of gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used to prevent Mendelson's syndrome through pre-anesthetic administration and to treat postoperative gastric ulcers. It is effective for gastric and duodenal ulcers caused by the use of nonsteroidal anti-inflammatory drugs (NSAIDs). It improves gastric mucosal lesions such as erosion, bleeding, redness, and swelling that occur during acute exacerbations of acute and chronic gastritis, and it also helps treat diseases related to upper gastrointestinal bleeding. Furthermore, it is used to relieve heartburn and acid reflux caused by excessive gastric acid. Overall, it acts effectively in treating gastrointestinal diseases and protecting the gastric mucosa.

How to take

Adult dose

Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The same dosage and administration apply to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Reflux esophagitis: Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. Zollinger-Ellison syndrome: Begin treatment with an initial dose of 150 mg of this medicine 3 times daily, and increase the dose as needed. For severe cases, up to 6 g per day may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg of this medicine twice daily. Preanesthetic medication (prevention of Mendelson syndrome): Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is also preferable to administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis: Administer 150 mg of this medicine once daily at bedtime. For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Child dose

Ages 8 〜 18 years: 150 mg per dose (2 mg per kg of body weight) may be administered up to twice daily. Patients 12 years of age and older: Administer 75 mg of this medicine orally twice daily (liquid formulation only).

Precautions

This medication should not be used in patients with a history of hypersensitivity to any component of this drug or a history of acute porphyria. Patients with impaired renal function may have increased blood concentration of this medication since it is excreted through the kidneys; therefore, the dosage should be reduced or the dosing interval extended. Patients with impaired liver function, a history of drug hypersensitivity, and elderly patients should also use it with caution. Patients taking nonsteroidal anti-inflammatory drugs should be monitored regularly. This medication may mask symptoms of gastric cancer, so patients with gastric ulcers or middle-aged patients with new dyspeptic symptoms should verify malignancy before usage. Patients with gastric and duodenal ulcers caused by Helicobacter pylori need concurrent therapy to eradicate the bacteria. Rarely, shock or allergic reactions, blood abnormalities, liver dysfunction, cardiac rhythm disturbances, gastrointestinal symptoms, and psychiatric symptoms may occur while taking this medication; if these symptoms arise, use should be discontinued immediately and a doctor consulted. Regular blood tests and liver and kidney function tests should be performed to confirm normality during treatment. The risk of pneumonia may be increased in the elderly, patients with chronic diseases, and those with weakened immune systems. If dizziness or drowsiness occurs after taking this medication, avoid driving or operating hazardous machinery. There may be interactions with other medications; careful monitoring of blood coagulation status is required, especially in patients taking anticoagulants like warfarin. When taking with drugs such as sucralfate, dosing should be spaced at least 2 hours apart as it may interfere with absorption. Women who are pregnant or potentially pregnant and nursing mothers should carefully weigh the benefits and risks before using this medication. Safety for use in children has not been adequately confirmed; caution is needed. Elderly patients may have increased medication concentrations due to decreased kidney function; therefore, dosage adjustment may be necessary. Some tests may yield false-positive results due to this medication, so care should be taken with testing methods. In case of overdose, gastric lavage or appropriate treatment is required, and in severe cases, blood dialysis may be needed. Store out of reach of children and do not transfer medication to other containers for safety.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • neutropenia
  • elevated serum creatinine
Show 57 more
  • leukopenia
  • thrombocytopenia
  • bone marrow suppression
  • aplastic anemia
  • refractory anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous and mucosal bleeding
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • heart block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal bloating
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • seizures
  • headache
  • heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • hepatic myoclonus
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that protects it from light. Additionally, it is important to store it at room temperature between 1°C and 30°C. This will help maintain the effectiveness of the medication and ensure safe usage.

Appearance and packaging

Appearance

Cream to pale yellow round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.